PADERBORN, Germany & LAS VEGAS--(BUSINESS WIRE)--#CES2024--dSPACE, one of the world’s leading providers of simulation and validation solutions, is expanding its partnership with the Indy Autonomous Challenge (IAC) and will support its university racing teams not only with hardware, but...
PITTSBURGH--(BUSINESS WIRE)--Alcoa Corporation (NYSE: AA) today announced it plans to fully curtail production in 2024 at its Kwinana Alumina Refinery in Western Australia, with the process beginning in the second quarter.
The Kwinana refinery has an annual nameplate production capacity...
– Newly published data highlights additional efficacy endpoints from trial –
– Linaclotide is the first and only FDA-approved prescription therapy for children and adolescents aged 6-17 years with functional constipation –BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare...
LOS ANGELES--(BUSINESS WIRE)--#AIDS--AIDS Healthcare Foundation (AHF) sent an open letter today to the heads of the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), urging the two institutions to conduct an audit of their...
To be demonstrated at CES 2024, the new BSC2000 device from HaiLa Technologies is the world’s first monolithic chip implementing passive backscatter on Wi-Fi. Based on HaiLa’s foundational backscatter technology and the result of a collaboration between HaiLa and...
OMAHA, Neb.--(BUSINESS WIRE)--(BRK.A; BRK.B) – Berkshire Hathaway Inc. is pleased to announce that it has reached an agreement to fully settle the Delaware litigation, including all claims and counterclaims, between Pilot Corporation and Berkshire Hathaway Inc., Pilot Travel Centers...
Featuring high-performing Qi2 chargers and mighty GaN solutionsLAS VEGAS--(BUSINESS WIRE)--Belkin, a leading consumer electronics brand for 40 years, today introduced four new products across its mobile power and connectivity portfolios, underscoring Belkin innovation, design excellence, dedication to quality, and...
Expect to deliver 2023 total revenue of more than $210 million, at least 53% growth over 2022
Delivered 70,429 total test reports in 2023, an increase of 59% compared to 2022
Year-end 2023 cash, cash equivalents and marketable investment securities expected...
– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39% Using Constant Exchange Rate**) –
– Maintained Strong Balance Sheet with Year-End Cash and Investments Balance...
BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business...